Tuesday, October 27, 2026
HomeETFsGenmab Reaches Analyst Target Price

Genmab Reaches Analyst Target Price

In recent trading, shares of Genmab A/S (Symbol: GMAB) have crossed above the average analyst 12-month target price of $43.85, changing hands for $44.69/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation

www.nasdaq.com

RELATED ARTICLES

Most Popular

Recent Comments